Universitat Pompeu Fabra Upf 1

1. Methodology for the Development of the Allergic Rhinitis and Its Impact on Asthma (ARIA)-EAACI 2024–2025 Guidelines: From Evidence-to-Decision Frameworks to Digitalised Shared Decision-Making Algorithms
2. Patient-centered digital biomarkers for allergic respiratory diseases and asthma: The ARIA-EAACI approach – ARIA-EAACI Task Force Report
3. Rhinitis associated with asthma is distinct from rhinitis alone: The ARIA-MeDALL hypothesis
4. Allergen immunotherapy in MASK-air users in real-life: Results of a Bayesian mixed-effects model
5. Behavioural patterns in allergic rhinitis medication in Europe: A study using MASK-air^® real-world data
6. Comparison of rhinitis treatments using MASK-air® data and considering the minimal important difference
7. Consistent trajectories of rhinitis control and treatment in 16,177 weeks: The MASK-air® longitudinal study
1